Literature DB >> 25696014

T-cell/histiocyte-rich large B-cell lymphoma in pediatric patients: an under-recognized entity?

Gabriela Gheorghe1, Hemalatha G Rangarajan2, Bruce Camitta3, Annette Segura4, Steven Kroft5, James F Southern4.   

Abstract

T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a distinct subtype of diffuse large B-cell lymphoma (DLBCL) under-recognized in the pediatric population. A meticulous workup is necessary to avoid a misdiagnosis of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) or classical Hodgkin lymphoma (HL). A strong degree of suspicion and an emphasis on immunohistochemical staining are required to reach the diagnosis. Few children with advanced stage disease have been described to date. We report two pediatric patients with high stage THRLBCL and highlight their clinical and pathological features.
© 2015 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Hodgkin lymphoma; Nodular Lymphocyte Predominant Hodgkin Lymphoma; T-cell/histiocyte-rich Large B-cell lymphoma; bone marrow; pediatric

Mesh:

Year:  2015        PMID: 25696014

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  2 in total

1.  T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report.

Authors:  Yajuan Shao; Chunmei Bai; Jian Sun; Xin Gao
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

2.  T-cell/histiocyte-rich large B-cell lymphoma in a child: A case report and review of literature.

Authors:  Chapman Wei; Chaplin Wei; Omar Alhalabi; Lei Chen
Journal:  World J Clin Cases       Date:  2018-06-16       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.